氧化磷脂与钙化性主动脉瓣疾病
本研究在MESA队列及4项随机试验的个体水平荟萃分析中评估OxPL-apoB和Lp(a)与钙化性主动脉瓣疾病的关系。结果显示OxPL-apoB可预测主动脉瓣钙化的存在、发生和进展,尤其在Lp(a)升高时,提示其可能为CAVD的新治疗靶点。
要点
- OxPL-apoB和Lp(a)均与基线主动脉瓣钙化相关,且存在显著交互作用
- OxPL-apoB可预测9.5年主动脉瓣钙化发生及已确立AS的进展
- Lp(a)升高时OxPL-apoB的预测价值更强,OxPL-apoB可能为治疗靶点
核心结论
- OxPL-apoB可预测主动脉瓣钙化的存在、发生和进展尤其是Lp(a)升高时,可能为CAVD的新治疗靶点。
研究设计与样本
- 研究包含MESA队列及4项已确立主动脉瓣狭窄患者的随机试验的个体水平荟萃分析。
主要发现
- MESA中OxPL-apoB和Lp(a)与基线主动脉瓣钙化相关(OR每SD分别为1.19 [95%CI:1.07-1.32]和1.13 [95%CI:1.01-1.27]),二者交互作用显著(P<0.01)。
- MESA中OxPL-apoB和Lp(a)分别与9.5年主动脉瓣钙化发生相关(交互P<0.01)。
- 荟萃分析中单独分析时OxPL-apoB和Lp(a)均与主动脉瓣峰值流速增快相关,同时评估时仅OxPL-apoB保持显著(ß:0.07;95%CI:0.01-0.12)。
关键数值与推荐
- MESA中基线主动脉瓣钙化:OxPL-apoB OR每SD 1.19(95%CI:1.07-1.32),Lp(a) OR每SD 1.13(95%CI:1.01-1.27)。
- 荟萃分析中主动脉瓣狭窄进展:同时评估时OxPL-apoB的ß为0.07(95%CI:0.01-0.12)。
临床怎么用
- OxPL-apoB可用于评估钙化性主动脉瓣疾病的存在、发生和进展风险,尤其在Lp(a)升高患者中。
- OxPL-apoB可能成为钙化性主动脉瓣疾病的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oxidized phospholipids (OxPLs) are carried by apolipoprotein B-100-containing lipoproteins (OxPL-apoB) including lipoprotein(a) (Lp[a]). Both OxPL-apoB and Lp(a) have been associated with calcific aortic valve disease (CAVD). OBJECTIVES: This study aimed to evaluate the associations between OxPL-apoB, Lp(a) and the prevalence, incidence, and progression of CAVD. METHODS: OxPL-apoB and Lp(a) were evaluated in MESA (Multi-Ethnic Study of Atherosclerosis) and a participant-level meta-analysis of 4 randomized trials of participants with established aortic stenosis (AS). In MESA, the association of OxPL-apoB and Lp(a) with aortic valve calcium (AVC) at baseline and 9.5 years was evaluated using multivariable ordinal regression models. In the meta-analysis, the association between OxPL-apoB and Lp(a) with AS progression (annualized change in peak aortic valve jet velocity) was evaluated using multivariable linear regression models. RESULTS: In MESA, both OxPL-apoB and Lp(a) were associated with prevalent AVC (OR per SD: 1.19 [95% CI: 1.07-1.32] and 1.13 [95% CI: 1.01-1.27], respectively) with a significant interaction between the two (P < 0.01). Both OxPL-apoB and Lp(a) were associated with incident AVC at 9.5 years when evaluated individually (interaction P < 0.01). The OxPL-apoB∗Lp(a) interaction demonstrated higher odds of prevalent and incident AVC for OxPL-apoB with increasing Lp(a) levels. In the meta-analysis, when analyzed separately, both OxPL-apoB and Lp(a) were associated with faster increase in peak aortic valve jet velocity, but when evaluated together, only OxPL-apoB remained significant (ß: 0.07; 95% CI: 0.01-0.12). CONCLUSIONS: OxPL-apoB is a predictor of the presence, incidence, and progression of AVC and established AS, particularly in the setting of elevated Lp(a) levels, and may represent a novel therapeutic target for CAVD.
引用
- Bhatia HS, Dweck MR, Craig N, et al. Oxidized Phospholipids and Calcific Aortic Valvular Disease. J Am Coll Cardiol. 2024. PMID: 39545902. doi:10.1016/j.jacc.2024.08.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。